To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
Clinical trial NCT02542605 · COMPLETED
Trial details
- NCT number
- NCT02542605
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-11
- Primary completion
- 2017-09-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.